Clinical Trials
92 trialsNOECHO
Skribe Medical
C-BREAST-01
Gazi University
G-COR
The Cleveland Clinic
Risk Stratification of Cancer Therapy-Related Cardiac Dysfunction Using AI-Enhanced Electrocardiography
Yonsei University
PCT
Abramson Cancer Center at Penn Medicine
SENTINEL
Abramson Cancer Center at Penn Medicine
ML-CardioTox
University Hospital, Caen
Evaluation of Impedance Cardiography for Assessing Hemodynamic Shifts in Patients With LA-NSCLC During Treatment.
Sun Yat-sen University
Dyspnea and Cardiotoxicity in Multiple Myeloma Patients Who Receive Carfilzomib
University of Chicago
CVE-CART
Abramson Cancer Center at Penn Medicine
Cardiotoxicity in Breast Cancer Patients Treated With Proton or Photon Radiotherapy: A RadComp Companion Study
Abramson Cancer Center at Penn Medicine
Effects of Immune Checkpoint Inhibitors on Coronary Microvasculature
Abramson Cancer Center at Penn Medicine
SCARA-B
Centre Paul Strauss
BRAVE-HEART
Fondazione IRCCS Policlinico San Matteo di Pavia
Cancer Therapy-Related Cardiac Dysfunction Associated With EGFR-TKIs in Advanced EGFR-mutant Non-small Cell Lung Cancer
Taichung Veterans General Hospital
Study Investigating the Cardiotoxicity of Anthracyclines in Patients With Diffuse Large B-Cell
Fondazione Italiana Linfomi - ETS
CARDIOTOX
Oncology Institute of Southern Switzerland
CCT2
Abramson Cancer Center at Penn Medicine
Role of Aerobic Exercise to Modulate Cardiotoxicity in Long Term Cancer Survivors Exposed to Anthracycline Therapy
Connecticut Children's Medical Center
PAtient Similarity for Decision-Making in Prevention of Cardiovascular Toxicity (PACT): A Feasibility Study
Medical College of Wisconsin
CLARITY
Abramson Cancer Center at Penn Medicine
CARD-IO
Royal Marsden NHS Foundation Trust
Study of Cardiopulmonary Exercise Testing in Women Who Have HER2-Positive Breast Cancer With Mild Cardiotoxicity
Memorial Sloan Kettering Cancer Center
Cardio CAR-T
Assistance Publique - Hôpitaux de Paris
Cardiac Magnetic Resonance Monitoring of Immune Checkpoint Inhibitor-related Cardiotoxicity
West China Second University Hospital
Generation of Heart Muscle Cells From Blood or Skin Cells of Breast Cancer Patients
Memorial Sloan Kettering Cancer Center
CLARITY
The Netherlands Cancer Institute
Cardio-Onco
University of Bern
Optimizing Radiation Dose and Utilizing Wearable Devices to Reduce Arrhythmia Risk in Patients Undergoing Thoracic Radiotherapy: A Prospective Cohort Study
Yonsei University
Determinants of Physical Activity Level in Pediatric Oncological Patients Treated With Cardiotoxic Therapy - a Study Protocol
Medical University of Warsaw
CV_CANCER
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Optimising Screening for the Cardiotoxic Effects of Cancer Therapy
Barts & The London NHS Trust
CATCH-HF
University of California, San Diego
Cardiovascular Function in Acute Leukemia
Abramson Cancer Center at Penn Medicine
BIOCAPRI
NHS Greater Glasgow and Clyde
SATIATION
University Hospital, Brest
BLOC-II
University Medical Center Groningen
Multimodal Assesment of Acute Cardiac Toxicity Induced by Thoracic Radiotherapy in Cancer Patients
Pontificia Universidad Catolica de Chile
Early Prediction and Warning for Cardiotoxicity Due to Anthracycline-Based Breast Cancer Chemotherapy
First Hospital of China Medical University
Late Anthracycline Induced Cardiotoxicity- Childhood Cancer Survivors
Queen's University, Belfast
COLA
Odense University Hospital
Cardiac Magnetic Resonance Imaging in Patients With Non-Hodgkin Lymphoma or Hodgkin Lymphoma Receiving Doxorubicin
University of Nebraska
Defining Robust Predictors of Chemotherapy Related Cardiotoxicity
University College, London
PC-TOX
University College, London
UCARE
National University of Ireland, Galway, Ireland
AQUA
Istanbul University
CASPER
Istanbul University
RADAF
Istanbul University
AMICI
Assistance Publique - Hôpitaux de Paris
CARTCO
University College London Hospitals